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Ethnopharmacological  relevance:  Indigofera  suffruticosa  is  specie  typical  of  the  “Cerrado”  or Brazilian  savan-
nah; it is  a  member  of  the  Fabaceae  family  – in  folkmedicine  is  used  for gastric  disorders,  infection  and
inﬂammation.
Aim  of  the  study:  Ethyl  acetate  fraction  (AcF)  and  aqueous  fraction  (AqF)  of  the  methanolic  extract  of  I.
suffruticosa  leaves  were  evaluated  against  acute  gastric  ulcer.  The  AcF  fraction  was  selected  to  assess  its
activity in ulcer  healing  and  its gastroprotective  effects  via  mucus  and  gastric  secretion.
Materials  and  methods:  The  gastroprotective  action  of AcF  and  AqF  fractions  were  evaluated  in  a  rodent
experimental  model.  The  action  mechanisms,  involvements  of the  antisecretory  action,  mucus  and
prostaglandin  production,  toxicological  and healing  activity  of  the  AcF  (100  mg/kg,  p.o.)  were evaluated.
We  also  used  histological  analysis  (HE and  PAS)  and  immunohistochemical  (PCNA  and  HSP-70)  assays  to
evaluate  the  effects  of I.  suffruticosa.
Results:  AcF  signiﬁcantly  inhibited  the  gastric  mucosal  damage  caused  by ethanol.  This effect  was  sta-
tistically  signiﬁcant  in  100  mg/kg  group  compared  vehicle.  AcF  did  not  interfered  with  gastric  secretion,
signiﬁcantly  increased  the  PGE2 and  mucus  production  (validated  in  PAS  technique).  The  gastroprotection
was  attenuated  by  pretreatment  with  N-ethylmaleimide,  but  not  L-NAME.  In  acid-acetic-induced  ulcer
model AcF  accelerated  ulcer  healing.  Immunohistochemistry  analysis  showed  induction  of proliferating
cell  (PCNA)  and  heat  shock  protein  (HSP  70).
Conclusions:  These  results  showed  that  AcF  acted  as  gastroprotective  agent  stimulating  prostaglandin,
mucus  and  HSP70.. Introduction
Peptic ulcers are a common disorder of the entire gastroin-
estinal tract that occurs mainly in the stomach and the proximal
uodenum. This disease is multifactorial and its treatment faces
reat difﬁculties due to the limited effectiveness and severe side
ffects of the currently available drugs (Mota et al., 2009). Numer-
us plants and herbs are used to treat gastrointestinal disorders in
raditional medicine (Schmeda-Hirschmann and Yesilada, 2005).
∗ Corresponding author at: Departamento de Anatomia, Biologia Celular e Fisiolo-
ia,  Instituto de Biologia, Universidade Estadual de Campinas (UNICAMP), CP 6109,
EP  13083970, Campinas, SP, Brazil. Tel.: +55 19 35216192; fax: +55 19 35216184.
E-mail address: luiz ferreiraa@yahoo.com.br (A. Luiz-Ferreira).
378-8741     ©  2011 Elsevier Ireland Ltd. 
oi:10.1016/j.jep.2011.05.006
Open access under the Elsevier OA license. © 2011 Elsevier Ireland Ltd. 
There has been renewed interest in identifying new antiulcer
drugs from natural sources (Mota et al., 2009). The biodiversity
of Brazilian ﬂora, especially the Cerrado, a savannah like region
is very rich in medicinal plant species which present antiulcer
activities. Among the medicinal plants present in this region,
we ﬁnd the Indigofera suffruticosa Mill (Fabaceae). The specie is
known to be a rich source of glycoside ﬂavonoids derived from
quercetin and alkaloids (Calvo et al., 2009). In popular Brazil-
ian medicine, it has been used as an infusion or decoct to treat
infection and inﬂammation (Matos, 1999; Vieira et al., 2007). In
Cuba, this specie is used to treat gastrointestinal disorders, such as
Open access under the Elsevier OA license. gastrointestinal pain (Roig, 1988). Recent pharmacological stud-
ies shown that I. truxillensis Kunth present antiulcerogenic and
antioxidant activity (Cola-Miranda et al., 2006; Farias-Silva et al.,
2007).
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The present work was carried out to investigate the possible
ntiulcerogenic effect of the ethyl acetate fraction (AcF) of leaves
f I. sulffruticosa Mil  against acute and chronic experimental mod-
ls of gastric ulcer in rodents. The possible mechanism of action of
cF was also studied. Finally, we also performed an immunohis-
ochemistry analysis for proliferating cell nuclear antigen (PCNA)
nd heat shock protein (HSP 70).
. Materials and methods
.1. Animals
Male Unib: WH rats (180–250 g) obtained from the breeding of
he State University of Campinas (CEMIB/UNICAMP) Brazil, were
sed. The colony rats were fed a certiﬁed Nuvilab CR-diet, with
ree access to tap water, and were housed on a 12 h light/dark cycle
t 60 ± 1% humidity and 21.5 ± 2 ◦C. The experimental protocols
ere approved by the institutional Committee for Ethics in Animal
xperimentation (CEEA/UNICAMP) and were done in accordance
ith the Canadian Council Guide lines for Animal Care.
.2. Plant material
The aerial parts of I. suffruticosa were collected along the
omingos Sartori highway at Rubião Junior, Botucatu, São Paulo
tate, Brazil, in June 2003. The plants were identiﬁed by Dr. Jorge
amashiro of the Institute of Biology at UNICAMP and a voucher
pecimen (UEC: 131.827) was deposited in the Herbarium at UNI-
AMP.
.3. Preparation of fractions
The aerial parts (1500 g) of I. suffruticosa were air dried (7 days at
0 ◦C), powdered, and then exhaustively extracted with chloroform
CHCl3) and methanol (MeOH) successively, at room temperature
three chloroform-methanol cycles, with 72 h for each solvent). The
olvents were evaporated in vacuum to provide a CHCl3 extract
nd a MeOH extract. A portion (3.0 g) of the MeOH extract was
artitioned in ethyl acetate and water (1:1, v/v) to yield 2.3 g and
.5 g of the AqF and AcF respectively.
.4. Determination of the total ﬂavonoid content
The ﬂavonoid content of the AcF was determined as follows:
.1 ml  of each fraction was diluted with 80% aqueous ethanol
0.9 ml)  and an aliquot of 0.5 ml  was added to test tubes containing
.1 ml  of 10% aluminum nitrate, 0.1 ml  of 1 M aqueous potassium
cetate and 4.3 ml  of 80% ethanol. After 40 min  at room tempera-
ure, the absorbance was determined at 415 nm. The total ﬂavonoid
ontent was calculated using quercetin as a standard (Moreno et al.,
000).
.5. Drugs
The following drugs were used: cimetidine, lansoprazole, car-
enoxolone, indomethacin, and N-ethyl-maleimide (NEM) were all
btained from Sigma Chemical Co. (St. Louis, MO, USA). The chemi-
als used and other solutions were all of analytical grade. All drugs
nd reagents were prepared immediately before use.
.6. Antiulcerogenic acitivity.6.1. Ethanol-induced gastric lesions
Ethanol-induced ulcers were produced in rats according to the
ethod of Morimoto et al. (1991).  Rats were randomly separated
nto ten groups and fasted for 24 h before the experiment. One hourarmacology 137 (2011) 192– 198 193
after the oral administration of AcF from I. suffruticosa (25, 50, and
100 mg/kg), lansoprazole (30 mg/kg), 12% Tween 80 (10 mL/kg),
1 ml  of 99.5% ethanol was given orally to the rats. Animals were
killed by cervical dislocation 1 h after ethanol administration. Their
stomachs were removed, opened along the greater curvature, and
ﬁxed between two glass plates. The inner surface of the stomach
was  examined with a dissecting microscope (Nikon SMZ800) and
the number of gastric lesions was  counted. The ulcer index was
calculated according to the method of Szelenyi and Thiemer (1978).
2.6.2. Gastric secretion in lesions induced by pylorus ligature
For this assay, the method of Shay et al. (1945) was used with
some modiﬁcations. Rats were fasted for 36 h and immediately after
pylorus ligature, AcF from I. suffruticosa (100 mg/kg), cimetidine
(100 mg/kg), 12% tween 80 (10 mL/kg) was administered intraduo-
denally. The rats were killed 4 h later, and their abdomens were
opened and the stomachs removed. The gastric juice was  collected
and weighed (g) and its pH were determined using a pH meter
(Quimis Aparelhos Cientíﬁco Ltda, model Q400A, Brazil).
2.6.3. Prostaglandin synthesis determination
Male rats were divided into 5 groups (n = 6). After a 24 h fast,
the animals received a pretreatment of saline, s.c. (groups 1 and
2), or indomethacin (dissolved in 5% sodium bicarbonate solution)
30 mg/kg, s.c. (groups 3 and 4). The ﬁfth group consisted of the
sham control animals. Thirty minutes after pretreatment, saline
(groups 1 and 3) or AcF 100 mg/kg (groups 2 and 4) was adminis-
tered orally. Thirty minutes after treatments, all the animals were
sacriﬁced and their abdomens opened. A sample of the corpus (full
thickness) was excised, weighed and suspended in 1 mL  of 1 mM
sodium phosphate buffer, pH 7.4. The tissue was ﬁnely minced with
scissors and then incubated at 37 ◦C for 20 min. PGE2 in the buffer
was  measured by the enzyme immunoassay (R&D systems) and the
absorbance was read at 450 nm (Curtis et al., 1995).
2.6.4. Determination of the gastric mucus content
This assay was  done as described by Rafatullah et al. (1990) with
some modiﬁcations. After a 36 h fast, rats received AcF from I. suf-
fruticosa (100 mg/kg), carbenoxolone (200 mg/kg), 12% Tween 80
(10 mL/kg) orally. Thirty minutes after treatment, the pylorus was
ligated. The animals were killed by cervical dislocation 4 h after
pylorus ligation and the glandular portion of the stomachs were
removed and weighed. Each segment was  immediately immersed
in 10 ml  of 0.1% Alcian blue solution (0.16 M sucrose/0.05 M sodium
acetate, pH 5.8) for 2 h, after which the excess dye was  removed
by two successive rinses with 10 ml of 0.25 M sucrose, ﬁrst for
15 min  and then for 45 min. Each stomach was than transferred to
0.5 M magnesium chloride solution for 2 h. Four milliliters of the
dye solution was  then vigorously shaken with an equal volume
of ether and the resulting emulsion was  centrifuged at 2000 × g
and the absorbance of the aqueous layer was measured at 580 nm.
The amount of blue dye extracted per gram of wet  glandular tis-
sue was  then calculated from a standard curve of dye prepared in
sucrose-acetate solution.
2.6.5. Determination of the role of nitric oxide (NO) and
sulfhydryl compounds (SH) in gastric protection
Male rats (n = 5) were divided into 6 groups and pretreated (i.p.)
with saline, L-NAME (N-nitro-l-arginine methyl 70 ester mg/kg) an
inhibitor of the NO synthesis or NEM (N-ethylmaleimide, 10 mg/kg)
a blocker of SH compounds (Arrieta et al., 2003). Thirty minutes
after the pretreatment the animals were administered (p.o.) vehi-
cle, carbenoxolone (100 mg/kg) or AcF (100 mg/kg). After 60 min
all the groups received 1 mL  absolute ethanol to induce gastric
1 thnopharmacology 137 (2011) 192– 198
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Table 1
Effects of lansoprazole (30 mg/kg), AqF and AcF from I. suffruticosa (25, 50 and
100 mg/kg) on ethanol-induced gastric mucosal ulcers in rats. The results are
reported as the mean ± S.D. ANOVA followed by Tukey’s test.
Treatments (p.o.) Dose (mg/kg) Ulcer index Inhibition (%)
12% Tween 10 mL/kg 34.4 ± 6.3 –
Lansoprazole 30 8.4 ± 3.6** 75
AcF  – I. suffruticosa 25 33.8 ± 4.9 1.7
50 33.8 ± 3.5 1.7
100 9.8 ± 3.7** 71
Saline 10 mL/kg 51.2 ± 16.8 –
Lansoprazole 30 9.2 ± 3.5** 82
AqF  – I. suffruticosa 25 35.4 ± 8.0 –
Still looking for a possible mechanism for the increase in the gas-
tric mucosa protective factors, we  investigated the effect of AcF on
mucus production. Fig. 2, shows that pretreatment with carbenox-
Table 2
Effects of intraduodenal adminstration of cimetidine (100 mg/kg) and AcF from I.
suffruticosa (100 mg/kg) on the biochemical parameters of gastric juice in pylorus-
ligated rats. The results are the mean ± SD of ﬁve rats per group. ANOVA followed
by Dunnett’s test.
Treatments (p.o.) Dose (mg/kg) pH (units) Gastric juice (mg)94 A. Luiz-Ferreira et al. / Journal of E
lcers. One hour after receiving ethanol the rats were killed for
etermination of gastric lesions.
.6.6. Healing in acetic-induced gastric lesion
The experiment was done according to the method described by
akagi et al. (1969) with some modiﬁcations Okabe and Amagase
2005). Three groups of male Unib: WH rats fasted for 24 h were
sed in this experiment (n = 5). Under anesthesia, a laparotomy
as done in all animals through a midline epigastric incision. After
xposing the stomach, 0.05 ml  (v/v) of a 30% acid acetic solution
as injected into the subserosal layer in the glandular part of
he anterior wall. The stomach was bathed with saline (20 ◦C) to
void adherence to the external surface of the ulcerated region.
he abdomen was then closed and all the animals were fed nor-
ally. We  selected the lower effective dose of AcF (100 mg/kg) of
. suffruticosa; cimetidine (100 mg/kg) or vehicle (10 mL/kg) for the
etermination of the healing effects by the subacute treatment. All
reatments were done orally once a day during 14 consecutive days
eginning one day after surgery.
One day after the last drug administration, the rats were killed
nd the stomachs were removed. The gastric lesions were evaluated
y examining the inner gastric surface with a dissecting magnifying
lass. The macroscopic ulcer area (mm2) and curative ratio (%) were
ubsequently determined as described by Takagi et al. (1969).
.6.7. Histology methods
The stomach of the rats submitted by different treatment of gas-
ric ulcers in the acid acetic model with different treatments were
ushed off and opened by the large curves and the lesion was local-
zed. The lesion was sectioned, and ﬁxed in ALFAC solution (alcohol,
hloroform and acetic acid) for 24 h in 4 ◦C. Then the samples were
outine processed for embedding in paraplast, and cut into 7 m
hick section. Hematoxylin and eosin and PAS (Behmer et al., 1976;
acca, 1985). The samples were analysed with a Leica microscope
ssociated with Leica Qwin Software (Leica-England).
.6.8. Immunohistochemical methods
The histological cuts were deparafﬁnized, rehydrated and
mmunostained by the ABC method. Nonspeciﬁc reaction was
locked with H2O2 and goat serum prior to the incubation with
he speciﬁc antiserum. After rinsing in phosphatase buffer saline
PBS 0.01 mol/L, pH 7.4), the sections were incubated in secondary
ntiserum (ABC kit). They were washed in PBS buffer, the ABC
omplex was applied, and the reaction was ﬁnally carried out in a
AB solution (3,3′-diaminobenzidine-tetrahydrochloride) contain-
ng 0.01% H2O2 in PBS buffer. After immunostaining, the sections
ere lightly counterstained with hematoxylin and the immunore-
ctive cells were observed under a Leica microscope associated
ith Leica Qwin Software (Leica-England). For the control reac-
ion, some slides were processed omitting the primary antibody
nd other slides omitting the primary and secondary antibodies.
hese procedures were done for heat-shock protein 70 (HSP-70-
anta Cruz Biotechnology) and Proliferating cell nuclear antigen
PCNA-Novo Castra).
.7. Statistical analysisThe results were expressed as the mean ± standard derivation.
tatistical comparisons were done by one-way analysis of variance
ANOVA) followed by the Dunnett’s or Tukey’s post hoc test, with
he level of signiﬁcance set at p < 0.05.50 41.0 ± 2.4 –
100 40.8 ± 10.5 –
** P < 0.01 compared to the corresponding vehicle group.
3. Results
3.1. Ethanol-induced gastric lesions
The oral doses (25, 50 and 100 mg/kg) were initially used to
establish a general proﬁle of the antiulcerogenic activity of the both
AcF and AqF (Table 1). These data suggest that AcF (100 mg/kg)
produce a gastroprotective effect since they signiﬁcantly reduced
ethanol-induced ulcers. However, the AcF fraction failed to reduce
the gastric lesions that had been induced by absolute ethanol. The
dose of 100 mg/kg of AcF demonstrated 71% protection against
gastric ulcer induced by ethanol absolute when compared with
respective control. Therefore, with the purpose of investigating the
probable gastroprotective mechanisms involved in the action pro-
moted by AcF, we continued our studies using only a single dose
100 mg/kg in subsequent assays, since it had produced the best
results in this model.
3.2. Gastric secretion in lesions induced by pylorus ligature
The antiulcerogenic activity of AcF (100 mg/kg) was unrelated to
the mechanisms that control gastric acid secretion. In the model of
pyloric ligature, pretreatment with AcF did not signiﬁcant modify
the pH of gastric juice (Table 2).
3.3. Prostaglandin synthesis determination
Fig. 1 shows that AcF (100 mg/kg) was able to maintain a high
PGE2 level despite administration of indomethacin. AcF was able
to promote a sustained increase of PGE2 levels, which is vital to
the integrity of gastric mucosa. Furthermore, the association of AcF
and NSAID was  not capable of reducing levels of PGE2 release in a
signiﬁcant manner.
3.4. Determination of the gastric mucus content12% Tween 10 mL/kg 3 ± 0 0.8 ± 0.4
Cimetidine 100 4 ± 0** 0.8 ± 0.4
AcF – I. suffruticosa 100 3.4 ± 0.5 1 ± 0
** P < 0.01 compared to the corresponding vehicle group.
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Fig. 3. The ulcer index for gastric ulcers induced by ethanol in rats pretreated
with NEM (10 mg kg−1) alone or together with carbenoxolone (100 mg/kg) and AcF
(100 mg/kg) of I. suffruticosa. The results are reported as the mean ± S.D. ANOVA
followed by Tukey’s test. p < 0.05 compared to the corresponding vehicle group.
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Fig. 4. The ulcer index for gastric ulcers induced by ethanol in rats pretreated with
L-NAME (10 mg/kg) alone or together with carbenoxolone (100 mg/kg) and AcF
(100 mg/kg) of I. suffruticosa. The results are reported as the mean ± S.D. ANOVAndomethacin on gastric prostaglandin E2 (PGE2) production in rats. The results are
eported as the mean ± S.E.M. ANOVA followed by Tukey’s test. p < 0.05 compared
o the corresponding vehicle group.
lone (200 mg/kg) and AcF (100 mg/kg) signiﬁcantly increased the
mount of adherent mucus in the gastric mucus mucosa when com-
ared to the control group.
.5. Determination of the role of nitric oxide (NO) and sulfhydryl
ompounds (SH) in gastric protection
Fig. 3, shows that N-ethylmaleimide (NEM) an SH blocker, sig-
iﬁcant attenuated the gastroprotective effect of AcF (100 mg/kg),
hich suggested that part of the protective action was mediated
y endogenous SHs. On the other hands, when we administered
-NAME, an NO blocker, the gastroprotection was  slightly affected
Fig. 4).
.6. Healing in acetic-induced gastric lesion
In our experiments, the oral administration of AcF (100 mg/kg)
or 14 consecutive days accelerated the healing of gastric ulcers
40%) in rats. The cimetidine group, utilized as positive group, accel-
rated the healing of gastric by 66% (Fig. 5).
.7. ImmunohistochemistryIn intention to evaluate the mechanism of healing of the gastric
lcer promoted by the AcF (100 mg/kg) histological analysis in the
tomachs of the animals with acid acetic-induced gastric ulcer. We
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ig. 2. Effect of orally administered AcF (100 mg/kg) from I. suffruticosa and car-
enoxolone (200 mg/kg) on the production of adherent gastric mucus (measured as
he  amount of bound alcian blue) in pylorus-ligated rats. The results are reported as
he  mean ± S.D. ANOVA followed by Dunnet’s test. p < 0.01 compared to the corre-
ponding vehicle group.
followed by Tukey’s test. p < 0.001 compared to the corresponding vehicle group.
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Fig. 5. Effect of orally administered AcF from I. suffruticosa on healing of ulcers pro-
duced by the injection of a 30% acetic acid solution into the stomachs of rats. The
ulceration was scored on the 15th day after surgery. The results are reported as the
mean ± S.D. ANOVA followed by Tukey’s test. p < 0.05 compared to the correspond-
ing  vehicle group.
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Fig. 6. Acetic-acid-induced gastric ulcer on day 14 after ulcer induction. Histological analyses of stomach of rat (A) vehicle (10 mL/kg), (B) cimetidine (100 mg/kg) and (C)
AcF  of I. suffruticosa (100 mg/kg), PAS method.
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tig. 7. Acetic-acid-induced gastric ulcer on day 14 after ulcer induction. Immunoh
nimals  treated with Vehicle (10 mL/kg), (B) cimetidine (100 mg/kg) and (C) AcF of 
nvestigated the gastric mucus production (PAS) and involvement
f proliferating cell nuclear antigen (PCNA) and heat shock protein
HSP70).
The increased gastric mucus production using AcF was veriﬁed
ia an increase in PAS-positive mucus (Fig. 6) and it is an indica-
ive of a gastroprotection a number of factors appear to inﬂuence
lcer healing; but mucus and bicarbonate secretion may  be impor-
ant in the ulcer healing process. In the morphologic analysis of the
ubmitted slides with PCNA (Fig. 7), in all groups were observed
ell proliferation, in AcF (100 mg/kg) there are cell proliferation in
ase of mucosa glands in lesion region. When we evaluated the
mmunostained area for HSP-70 was larger in cimetidine and AcF
100 mg/kg) groups, which indicates that these proteins partici-
ated in the gastroprotective effect of the AcF (Fig. 8).
. DiscussionPeptic ulcer disease embraces both gastric and duodenal ulcers
nd has been a major threat to the world’s population over the
ast two centuries, with a high morbidity and substantial mortality
Malfertheiner et al., 2009). It is estimated that peptic ulcer occurs
ig. 8. Acetic-acid-induced gastric ulcer on day 14 after ulcer induction. Immunohistoch
reated with vehicle (10 mL  kg−1), (B) cimetidine (100 mg/kg) and (C) AcF of I. suffruticosaemical staining of proliferating cell nuclear antigen (PCNA) in the margin ulcer of
uticosa (100 mg/kg).
in at least 10% of the world population (Grob, 2004). The complex
and multifactorial pathogenesis of peptic ulcer has been studied
over several decades, and results from an imbalance of aggres-
sive gastric luminal factors acid and pepsin and defensive mucosal
barrier function (Mota et al., 2009).
The present study was designed to assess the antiulcerogenic
activity and action mechanisms of an AcF of I. suffruticosa. The phy-
tochemical screening indicated that the main constituents of the
AcF were ﬂavonoid glycosides derived from quercetin and alka-
loids.
Flavonoids and alkaloids protect the gastric mucosa against
a variety of ulcerogenic agents in different mammalian species
(de Sousa Falcão et al., 2008; Mota et al., 2009). Several mecha-
nisms have been proposed to explain the gastroprotective effect of
ﬂavonoids; these include anti-secretory, cytoprotective and antiox-
idant activity (Mota et al., 2009). Recent studies showed that the
alkaloid indigo obtained from Indigofera truxilensis signiﬁcantly
inhibits gastric lesions in rats (Farias-Silva et al., 2007).
Studies focusing on the pathogenesis of ethanol-induced gastric
mucosal injury suggest that ethanol acts by exerting a direct toxic
effect on the epithelium, leading to the formation of characteristic
emical staining of Heat Shock Protein 70 (HSP70) in the margin ulcer of animals
 (100 mg/kg).
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ecrotic lesions due to a reduction in the mucus production and
icarbonate secretion (Massignani et al., 2009) that initial event is
isruption of the vascular endothelium resulting in increased vas-
ular permeability, edema formation, and epithelial lifting (Kvietys
t al., 1990).
It is well known that ethanol-induced gastric lesions are not
nhibited by anti-secretory agents like cimetidine, but are inhib-
ted by agents who enhance mucosal defensive factors (Morimoto
t al., 1991). The gastroprotetive effect observed in our ethanol-
nduced ulcer model indicates that AcF (100 mg/kg) enhanced the
ytoprotective mechanisms of the gastric mucosa, since it does not
lter the secretion acid.
Non-steroidal anti-inﬂammatory drugs (NSAID) are one of the
ost widely prescribed medication in the world (Sostres et al.,
010). NSAID injures the upper and lower gut by depleting COX-1
erived prostaglandins and causing topical injury to the mucosa
Sostres et al., 2010). Prostaglandins play important roles in
odulating the mucosal integrity and various functions of the
astrointestinal tract (Malfertheiner et al., 2009). We  observed
hat a single AcF treatment was able to increase PGE2 level of
astric mucosa (5692 ± 180.4 pg/well) when compared to vehicle
roup (3512 ± 368.4 pg/well). AcF signiﬁcantly (p < 0.05) increased
GE2 to levels approximately 38% those in the vehicle group.
ut when AcF was administered jointly with indomethacin, a
yclooxygenase inhibitor, this fraction still maintained higher PGE2
evels (3968 ± 489.5 pg/well). The same results did not occur under
reatments with vehicle and NSAID, since NSAID administration
igniﬁcantly diminished the PGE2 levels (1466 ± 593 pg/well).
Mucus contributes to mucosal defense by providing a physical
arrier against bacteria and acts as a lubricant to reduce physi-
al abrasion of the mucosa. Mucus also protects the mucosa from
amage induced by acid and luminal toxins (Laine et al., 2008). Pre-
reatment with AcF-induced signiﬁcant increase of gastric mucus
roduction (27%), a rise which is correlated with its anti-ulcer effect
bserved throughout these studies.
A network of endogenous factor is involved in the regulation of
ucosal gastric functional homeostasis. We  evaluated the role of
ndogenous nitric oxide (NO) and sulfhydryl compounds (SH) in the
astroprotective action of AcF. When we observed that even with
he nitric oxide synthetase inhibitor (L-NAME), the pretreatment
ith AcF maintained its gastroprotective action against ethanol
astric damage (54%), thereby showing that its activity does not
epend on NO. But when the animals had been pretreated with
EM, a sulfhydryl (SH) inhibitor, the gastroprotective effects of
cF stopped acting on gastric mucosa. These results demonstrated
hat the activity of the AcF is directly related to the presence of SH
ompounds in the gastric mucosal barrier.
Sulfhydryl groups (SH) have a broad range of roles in the cell, and
he redox status of cysteine residues can affect the structure and
unction of numerous enzymes, receptors and transcription factors
Grant, 2001). SH have been implicated in the maintenance of gas-
ric integrity, particular when reactive oxygen species are involved
n the pathophysiology of tissue damage (Kimura et al., 2001).
ndogenous sulfhydryl radicals and other antioxidant mechanisms
ppear to play signiﬁcant roles in counteracting gastric injury asso-
iated with Helicobacter pylori infection (Jung et al., 2001).
The ulcer produced by the injection of acetic acid into the rat
tomach wall was assumed to be similar to the human chronic ulcer,
ince it is difﬁcult to be treated and it takes a long time to be healed
Takagi et al., 1969). Studies demonstrated that reepithelialized
ucosa of grossly “healed” experimental gastric ulcers has promi-
ent histologic and ultrastructural abnormalities reduced height,
arked dilation of gastric glands, increased connective tissue, a
isorganized microvascular network and increased capillary per-
eability (Tarnawski et al., 1991). These prominent abnormalitiesarmacology 137 (2011) 192– 198 197
may  interfere with mucosal defense and cause ulcer recurrence
when ulcerogenic factors are present (Tarnawski, 2005).
Postoperative treatment with AcF for 14 consecutive days
demonstrated, for the ﬁrst time, that this plant accelerated ulcer
healing. On the day 14 after surgery, the percentage of rats with
cicatrised ulcers in AcF was  signiﬁcantly higher than the vehicle
group.
Ulcer healing, a genetically programmed repair process,
includes inﬂammation, cell proliferation, reepithelialization, for-
mation of granulation tissue, angiogenesis, interactions between
various cells and the matrix and tissue remodeling, all resulting in
scar formation (Tarnawski, 2005).
Proliferating cell nuclear antigen (PCNA) is well known as a
cell cycle marker, is well known as a DNA sliding clamp for DNA
polymerase delta and as an essential component for eukaryotic
chromosomal DNA replication and repair (Naryzhny, 2008). In the
morphologic analysis of the submitted slides with PCNA, in all
groups were observed cell proliferation, in AcF there are cell prolif-
eration in base of mucosa glands in lesion region. Cell proliferating
also denotes that AcF induces the expression of the growth factor in
the gastric mucosa, thus leading to the gastric ulcer healing activity.
Heat Shock Protein (HSP) is generally induced when cells are
subjected to noxious stimuli (Okabe and Amagase, 2005). HSPs may
contribute to mucosal protection and ulcer healing by regulating
the activity of enzymes such as cyclooxygenase and nitric oxide
synthase (Rokutan, 2000), as well as by increasing mucosal blood
ﬂow (Shichijo et al., 2003).
We did not determine the histological localization, HSP70
appears to be expressed in growing cells in the ulcer margin. Indeed,
a strong relationship has been reported between the expression of
HSP70 and a marker for cell proliferation, such as PCNA as observed
in human breast cancer biopsy samples. Based on these ﬁndings, it
was  suggested that HSP70 expressed in the proliferating cells and
it was involved in the mucosal regeneration in the phase of ulcer
healing. In regards to HSP70, the level expressed in normal mucosa
was  quite low (Tsukimi et al., 2001).
5. Conclusion
In conclusion, the promising results found with the AcF obtained
from I. suffruticosa inhibited the gastric mucosal lesions induced
by ethanol and NSAID in rats. Prostaglandin, mucus and SHs are
involved in the gastroprotection by AcF. In addition, the expression
of PCNA and HSP70 contribute to accelerate the process of healing
of the gastric ulcer promoted by the AcF. In view of our results,
more precise investigation of their function could provide insight
into the mechanism of gastric cytoprotection and the role of active
ﬂavonoids and alkaloids presents in AcF.
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